In vivo visualization of enantioselective targeting of amyloid and improvement of cognitive function by clickable chiral metallohelices. Du, Z., Liu, C., Liu, Z., Song, H., Scott, P., Du, X., Ren, J., & Qu, X. CHEMICAL SCIENCE, 14(3):506–513, January, 2023.
doi  abstract   bibtex   
The pathogenesis of Alzheimer's disease (AD) is closely related to several contributing factors, especially amyloid-beta (A beta) aggregation. Bioorthogonal reactions provide a general, facile, and robust route for the localization and derivatization of A beta-targeted agents. Herein, a pair of chiral alkyne-containing metallohelices (lambda A and & UDelta;A) were demonstrated to enantioselectively target and modulate A beta aggregation, which has been monitored in triple-transgenic AD model mice and proved to improve cognitive function. Compared with its enantiomer & UDelta;A, lambda A performed better in blocking A beta fibrillation, relieving A beta-triggered toxicity, and recovering memory deficits in vivo. Moreover, clickable lambda A could act as a functional module for subsequent visualization and versatile modification of amyloid via bioorthogonal reaction. As a proof-of-concept, thioflavin T, tacrine, and magnetic nanoparticles were conjugated with lambda A to realize A beta photo-oxygenation, acetylcholinesterase inhibition, and A beta clearance, respectively. This proof-of-principle work provided new insights into the biolabeling and bioconjugation of multifunctional metallosupramolecules through click reactions for AD therapy.
@article{du_vivo_2023,
	title = {In vivo visualization of enantioselective targeting of amyloid and improvement of cognitive function by clickable chiral metallohelices},
	volume = {14},
	issn = {2041-6520},
	doi = {10.1039/d2sc05897a},
	abstract = {The pathogenesis of Alzheimer's disease (AD) is closely related to several contributing factors, especially amyloid-beta (A beta) aggregation. Bioorthogonal reactions provide a general, facile, and robust route for the localization and derivatization of A beta-targeted agents. Herein, a pair of chiral alkyne-containing metallohelices (lambda A and \& UDelta;A) were demonstrated to enantioselectively target and modulate A beta aggregation, which has been monitored in triple-transgenic AD model mice and proved to improve cognitive function. Compared with its enantiomer \& UDelta;A, lambda A performed better in blocking A beta fibrillation, relieving A beta-triggered toxicity, and recovering memory deficits in vivo. Moreover, clickable lambda A could act as a functional module for subsequent visualization and versatile modification of amyloid via bioorthogonal reaction. As a proof-of-concept, thioflavin T, tacrine, and magnetic nanoparticles were conjugated with lambda A to realize A beta photo-oxygenation, acetylcholinesterase inhibition, and A beta clearance, respectively. This proof-of-principle work provided new insights into the biolabeling and bioconjugation of multifunctional metallosupramolecules through click reactions for AD therapy.},
	number = {3},
	urldate = {2022-12-22},
	journal = {CHEMICAL SCIENCE},
	author = {Du, Zhi and Liu, Chun and Liu, Zhenqi and Song, Hualong and Scott, Peter and Du, Xiubo and Ren, Jinsong and Qu, Xiaogang},
	month = jan,
	year = {2023},
	pages = {506--513},
}

Downloads: 0